http://purl.org/np/RAUYV1aSHlkWQmnoRt4Xq8jsao5Xp1NNyC8fvY-Y9pAj4#Head http://purl.org/np/RAUYV1aSHlkWQmnoRt4Xq8jsao5Xp1NNyC8fvY-Y9pAj4 http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RAUYV1aSHlkWQmnoRt4Xq8jsao5Xp1NNyC8fvY-Y9pAj4#assertion http://purl.org/np/RAUYV1aSHlkWQmnoRt4Xq8jsao5Xp1NNyC8fvY-Y9pAj4 http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RAUYV1aSHlkWQmnoRt4Xq8jsao5Xp1NNyC8fvY-Y9pAj4#provenance http://purl.org/np/RAUYV1aSHlkWQmnoRt4Xq8jsao5Xp1NNyC8fvY-Y9pAj4 http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RAUYV1aSHlkWQmnoRt4Xq8jsao5Xp1NNyC8fvY-Y9pAj4#pubinfo http://purl.org/np/RAUYV1aSHlkWQmnoRt4Xq8jsao5Xp1NNyC8fvY-Y9pAj4 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RAUYV1aSHlkWQmnoRt4Xq8jsao5Xp1NNyC8fvY-Y9pAj4#assertion http://purl.obolibrary.org/obo/DOID_4450 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Disease http://purl.org/np/RAUYV1aSHlkWQmnoRt4Xq8jsao5Xp1NNyC8fvY-Y9pAj4#association http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://purl.obolibrary.org/obo/DOID_4450 http://purl.org/np/RAUYV1aSHlkWQmnoRt4Xq8jsao5Xp1NNyC8fvY-Y9pAj4#association http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate https://w3id.org/biolink/vocab/treats http://purl.org/np/RAUYV1aSHlkWQmnoRt4Xq8jsao5Xp1NNyC8fvY-Y9pAj4#association http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://identifiers.org/drugbank:DB08875 http://purl.org/np/RAUYV1aSHlkWQmnoRt4Xq8jsao5Xp1NNyC8fvY-Y9pAj4#association http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://purl.org/np/RAUYV1aSHlkWQmnoRt4Xq8jsao5Xp1NNyC8fvY-Y9pAj4#association http://www.w3.org/2000/01/rdf-schema#label cabometyx is a kinase inhibitor indicated for the treatment of patients with advanced renal cell carcinoma rcc 1 1 patients with hepatocellular carcinoma hcc who have been previously treated with sorafenib 1 2 cabometyx is indicated for the treatment of patients with advanced renal cell carcinoma rcc cabometyx is indicated for the treatment of patients with hepatocellular carcinoma hcc who have been previously treated with sorafenib http://purl.org/np/RAUYV1aSHlkWQmnoRt4Xq8jsao5Xp1NNyC8fvY-Y9pAj4#association https://w3id.org/biolink/vocab/association_type https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation http://purl.org/np/RAUYV1aSHlkWQmnoRt4Xq8jsao5Xp1NNyC8fvY-Y9pAj4#association https://w3id.org/biolink/vocab/provided_by https://w3id.org/um/NeuroDKG http://purl.org/np/RAUYV1aSHlkWQmnoRt4Xq8jsao5Xp1NNyC8fvY-Y9pAj4#association https://w3id.org/biolink/vocab/relation https://schema.org/TreatmentIndication https://identifiers.org/drugbank:DB08875 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Drug http://purl.org/np/RAUYV1aSHlkWQmnoRt4Xq8jsao5Xp1NNyC8fvY-Y9pAj4#provenance http://purl.org/np/RAUYV1aSHlkWQmnoRt4Xq8jsao5Xp1NNyC8fvY-Y9pAj4#assertion http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAUYV1aSHlkWQmnoRt4Xq8jsao5Xp1NNyC8fvY-Y9pAj4#pubinfo http://purl.org/np/RAUYV1aSHlkWQmnoRt4Xq8jsao5Xp1NNyC8fvY-Y9pAj4#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RAUYV1aSHlkWQmnoRt4Xq8jsao5Xp1NNyC8fvY-Y9pAj4#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB http://purl.org/np/RAUYV1aSHlkWQmnoRt4Xq8jsao5Xp1NNyC8fvY-Y9pAj4#sig http://purl.org/nanopub/x/hasSignature PY9rsFvFt/S93YflYkvFgbzlrUUbuMVBD8sZfUfDtMdJ9WP/OQwukmL7JhLyTFowArBc4xkPNuWFYgN5xqhOxKhXatuA8VL1C7obn4mI0T//jDaPt4piItZ1XeYroK4JQQbOtGrCzaquv4VTFgRTR+6myIOjWosjZ1eCqZsISiI= http://purl.org/np/RAUYV1aSHlkWQmnoRt4Xq8jsao5Xp1NNyC8fvY-Y9pAj4#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RAUYV1aSHlkWQmnoRt4Xq8jsao5Xp1NNyC8fvY-Y9pAj4 http://purl.org/np/RAUYV1aSHlkWQmnoRt4Xq8jsao5Xp1NNyC8fvY-Y9pAj4 http://purl.org/dc/terms/created 2021-06-12T12:21:44.793+02:00 http://purl.org/np/RAUYV1aSHlkWQmnoRt4Xq8jsao5Xp1NNyC8fvY-Y9pAj4 http://purl.org/dc/terms/creator https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAUYV1aSHlkWQmnoRt4Xq8jsao5Xp1NNyC8fvY-Y9pAj4 https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM http://purl.org/np/RAUYV1aSHlkWQmnoRt4Xq8jsao5Xp1NNyC8fvY-Y9pAj4 https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM http://purl.org/np/RAUYV1aSHlkWQmnoRt4Xq8jsao5Xp1NNyC8fvY-Y9pAj4 https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs